Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Agile Growth Corp.AGGR · Entity 115503 | Director | March 09, 2021 | March 09, 2021 |
| PROGRESS SOFTWARE CORP /MAPRGS · Entity 4559 | Director | March 31, 2017 | April 04, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Agile Growth Corp.
Report date March 09, 2021 · Filed March 09, 2021
This filing explicitly reported no securities owned.
PROGRESS SOFTWARE CORP /MA
Report date March 31, 2017 · Filed April 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 437,799 |
Reported balance
After 2017-03-31 transaction · row 1
1 source rowRow 1 · 2017-03-31 · Grant · Acquired 6,885 · Balance 437,799 F1: Represents deferred stock units acquired by Reporting Person pursuant to the Company's 2008 Stock Options and Incentive Plan and 2017 Fiscal Year Non-Employee Director Compensation Plan for services provided as a director applicable to the 2017 fiscal year. The deferred stock units are fully earned on December 1, 2017, subject to the Reporting Person's continued service on the Progress Software Corporation Board of Directors on such date. The deferred stock units are payable exclusively in common stock on a one-for-one basis on the earlier of a change in control of Progress Software Corporation or when Reporting Person ceases to provide services to the Company as a director following December 1, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock units acquired by Reporting Person pursuant to the Company's 2008 Stock Options and Incentive Plan and 2017 Fiscal Year Non-Employee Director Compensation Plan for services provided as a director applicable to the 2017 fiscal year. The deferred stock units are fully earned on December 1, 2017, subject to the Reporting Person's continued service on the Progress Software Corporation Board of Directors on such date. The deferred stock units are payable exclusively in common stock on a one-for-one basis on the earlier of a change in control of Progress Software Corporation or when Reporting Person ceases to provide services to the Company as a director following December 1, 2017.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Change Healthcare Inc.
Report date October 03, 2022 · Filed October 05, 2022
Section 16 reporting ended · disclosed 2022-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-10-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-10-03 · Disposition to issuer · Disposed 61,936 · Balance 40,706 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. Row 2 · 2022-10-03 · Disposition to issuer · Disposed 33,048 · Balance 7,658 F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. Row 3 · 2022-10-03 · Disposition to issuer · Disposed 7,658 · Balance 0 F3: At the Effective Time of the Merger, all restricted stock units of the Issuer automatically vested and were automatically converted into United restricted stock units calculated by taking the merger consideration of $25.75 per share of Common Stock of the Issuer and dividing it by the Equity Award Exchange Ratio and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer restricted stock units. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2027-10-17 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-10-03 · Disposition to issuer · Disposed 26,544 · Balance 0 F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4: These options are fully vested. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2028-05-25 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-10-03 · Disposition to issuer · Disposed 5,056 · Balance 0 F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4: These options are fully vested. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.92 · Expires 2022-11-28 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-10-03 · Disposition to issuer · Disposed 28,828 · Balance 0 F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4: These options are fully vested. |
| Stock Appreciation rightSEC Table II · derivative / convertible security · Conversion / exercise price $0.38 · Expires 2022-11-28 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-10-03 · Disposition to issuer · Disposed 11,439 · Balance 0 F6: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax.
F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units.
F3: At the Effective Time of the Merger, all restricted stock units of the Issuer automatically vested and were automatically converted into United restricted stock units calculated by taking the merger consideration of $25.75 per share of Common Stock of the Issuer and dividing it by the Equity Award Exchange Ratio and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer restricted stock units.
F4: These options are fully vested.
F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option.
F6: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerStock Appreciation right · Derivative | 11,439 | Not disclosed Strike: $0.38 | Not disclosed |
DisclosureSEC source: 0000899243-22-033017 · doc4.xml · derivative · entry 7 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,439 shares Expires 2022-11-28 F6 · price: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. F6 · derivative.exercise_date: These stock appreciation rights ("SARs") are fully vested. Pursuant to the Merger Agreement, the SARs were automatically converted into SARs of UnitedHealth Group, denominated in a number of shares of common stock of UnitedHealth Group equal to the product of the number of shares of Common Stock subject to the Issuer SARs multiplied by the Equity Award Exchange Ratio, at an exercise price per share equal to the strike price per share applicable to such SAR divided by the Equity Award Exchange Ratio. The UnitedHealth Group SARs will continue to be subject to the same terms and conditions as were applicable to the Issuer SARs. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerStock Option (right to buy) · Derivative | 28,828 | Not disclosed Strike: $7.92 | Not disclosed |
DisclosureSEC source: 0000899243-22-033017 · doc4.xml · derivative · entry 6 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,828 shares Expires 2022-11-28 F5 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerStock Option (right to buy) · Derivative | 5,056 | Not disclosed Strike: $18.99 | Not disclosed |
DisclosureSEC source: 0000899243-22-033017 · doc4.xml · derivative · entry 5 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,056 shares Expires 2028-05-25 F5 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerStock Option (right to buy) · Derivative | 26,544 | Not disclosed Strike: $18.99 | Not disclosed |
DisclosureSEC source: 0000899243-22-033017 · doc4.xml · derivative · entry 4 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,544 shares Expires 2027-10-17 F5 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 7,658 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033017 · doc4.xml · nonDerivative · entry 3 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: At the Effective Time of the Merger, all restricted stock units of the Issuer automatically vested and were automatically converted into United restricted stock units calculated by taking the merger consideration of $25.75 per share of Common Stock of the Issuer and dividing it by the Equity Award Exchange Ratio and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer restricted stock units. F3 · price: At the Effective Time of the Merger, all restricted stock units of the Issuer automatically vested and were automatically converted into United restricted stock units calculated by taking the merger consideration of $25.75 per share of Common Stock of the Issuer and dividing it by the Equity Award Exchange Ratio and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer restricted stock units. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 33,048 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033017 · doc4.xml · nonDerivative · entry 2 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,658 F2 · shares: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. F2 · price: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 61,936 | $25.75 | $1,594,852.00 |
DisclosureSEC source: 0000899243-22-033017 · doc4.xml · nonDerivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,706 F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 17:06 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 7,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-010880 · form4.xml · nonDerivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,642 F1 · shares: Represents the grant of restricted stock units that vest on April 25, 2023. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 14:26 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 7,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-005916 · form4.xml · nonDerivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,984 F1 · shares: Represents the grant of deferred stock units that vests on June 22, 2022. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:41 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 14,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-002929 · form4.xml · nonDerivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,848 F1 · shares: Represents the grant of deferred stock units that vests on June 17, 2021. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| May 01, 2020 Filed May 5, 2020 16:47 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantStock Appreciation Right · Derivative | 11,439 | Not disclosed Strike: $0.38 | Not disclosed |
DisclosureSEC source: 0001227485-20-000001 · primary_doc.xml · derivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,439 Underlying: Common Stock · 11,439 shares Expires 2022-11-28 F1 · kind: On May 1, 2020, pursuant to a Merger Agreement, dated as of April 30, 2020, entered into by and among Change Healthcare Solutions, LLC, a wholly owned subsidiary of the Issuer (the "Purchaser"), Change Healthcare Solutions MergerCo Inc., a wholly owned subsidiary of the Purchaser (the "Merger Sub"), eRx Network Holdings, Inc. (the "Target"), and other parties thereto, Merger Sub merged with and into Target, with Target being the surviving entity of such merger and becoming a wholly owned subsidiary of Purchaser (the "Merger"). In connection with the Merger, pursuant to a rollover arrangement with the Issuer, certain of the Reporting Person's equity awards of Target converted into equity awards of the Issuer. F1 · price: On May 1, 2020, pursuant to a Merger Agreement, dated as of April 30, 2020, entered into by and among Change Healthcare Solutions, LLC, a wholly owned subsidiary of the Issuer (the "Purchaser"), Change Healthcare Solutions MergerCo Inc., a wholly owned subsidiary of the Purchaser (the "Merger Sub"), eRx Network Holdings, Inc. (the "Target"), and other parties thereto, Merger Sub merged with and into Target, with Target being the surviving entity of such merger and becoming a wholly owned subsidiary of Purchaser (the "Merger"). In connection with the Merger, pursuant to a rollover arrangement with the Issuer, certain of the Reporting Person's equity awards of Target converted into equity awards of the Issuer. F2 · derivative.exercise_date: These stock appreciation rights are fully vested. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 17:22 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 11,426 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-022306 · doc4.xml · nonDerivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,362 F1 · shares: Represents the grant of deferred stock units that vests on August 1, 2020. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 19:28 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | GrantCommon Stock | 6,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-17-000002 · wf-form4_149133408816728.xml · nonDerivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,799 F1 · acquired: Represents deferred stock units acquired by Reporting Person pursuant to the Company's 2008 Stock Options and Incentive Plan and 2017 Fiscal Year Non-Employee Director Compensation Plan for services provided as a director applicable to the 2017 fiscal year. The deferred stock units are fully earned on December 1, 2017, subject to the Reporting Person's continued service on the Progress Software Corporation Board of Directors on such date. The deferred stock units are payable exclusively in common stock on a one-for-one basis on the earlier of a change in control of Progress Software Corporation or when Reporting Person ceases to provide services to the Company as a director following December 1, 2017. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 21:17 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Disposition to issuerRestricted Stock Units · Derivative | 48,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000011 · edgar.xml · derivative · entry 7 PEAD PHILIP M · CIK 0001227485 · Director · Former Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,508 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F8 · derivative.exercise_date: On January 19, 2016, the Reporting Person was granted 48,508 performance-based restricted stock units that vest based on Issuer's total shareholder return over a three-year period, as will be determined at the first meeting of the Issuer's compensation committee following November 30, 2018. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested performance-based restricted stock units were cancelled. F8 · derivative.expiration_date: On January 19, 2016, the Reporting Person was granted 48,508 performance-based restricted stock units that vest based on Issuer's total shareholder return over a three-year period, as will be determined at the first meeting of the Issuer's compensation committee following November 30, 2018. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested performance-based restricted stock units were cancelled. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 21:17 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Disposition to issuerRestricted Stock Units · Derivative | 18,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000011 · edgar.xml · derivative · entry 6 PEAD PHILIP M · CIK 0001227485 · Director · Former Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,658 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.exercise_date: On January 19, 2016, the Reporting Person was granted 22,389 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2016, subject to the continued employment of the Reporting Person with Issuer. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested restricted stock units were cancelled. F7 · derivative.expiration_date: On January 19, 2016, the Reporting Person was granted 22,389 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2016, subject to the continued employment of the Reporting Person with Issuer. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested restricted stock units were cancelled. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 21:17 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Disposition to issuerRestricted Stock Units · Derivative | 47,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000011 · edgar.xml · derivative · entry 5 PEAD PHILIP M · CIK 0001227485 · Director · Former Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,222 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 2, 2015, the Reporting Person was granted 47,222 performance-based restricted stock units that vest based on Issuer's total shareholder return over a three-year period, as will be determined at the first meeting of the Issuer's compensation committee following November 30, 2017. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested performance-based restricted stock units were cancelled. F6 · derivative.expiration_date: On March 2, 2015, the Reporting Person was granted 47,222 performance-based restricted stock units that vest based on Issuer's total shareholder return over a three-year period, as will be determined at the first meeting of the Issuer's compensation committee following November 30, 2017. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested performance-based restricted stock units were cancelled. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 21:17 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Disposition to issuerRestricted Stock Units · Derivative | 8,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000011 · edgar.xml · derivative · entry 4 PEAD PHILIP M · CIK 0001227485 · Director · Former Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,718 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2015, the Reporting Person was granted 17,436 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2015, subject to the continued employment of the Reporting Person with Issuer. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested restricted stock units were cancelled. F5 · derivative.expiration_date: On March 2, 2015, the Reporting Person was granted 17,436 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2015, subject to the continued employment of the Reporting Person with Issuer. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested restricted stock units were cancelled. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 21:17 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Disposition to issuerRestricted Stock Units · Derivative | 13,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000011 · edgar.xml · derivative · entry 3 PEAD PHILIP M · CIK 0001227485 · Director · Former Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,077 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 2, 2015, the Reporting Person was granted 26,154 performance-based restricted stock units based on Issuer performance in FY15. Upon determination of achievement for FY15, each restricted stock unit vests in five installments, with one-third vesting on April 1, 2016 and the remaining restricted stock units vesting in four equal semi-annual installments beginning, subject to the continued employment of the Reporting Person with Issuer. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested restricted stock units were cancelled. F4 · derivative.expiration_date: On March 2, 2015, the Reporting Person was granted 26,154 performance-based restricted stock units based on Issuer performance in FY15. Upon determination of achievement for FY15, each restricted stock unit vests in five installments, with one-third vesting on April 1, 2016 and the remaining restricted stock units vesting in four equal semi-annual installments beginning, subject to the continued employment of the Reporting Person with Issuer. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested restricted stock units were cancelled. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 21:17 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Disposition to issuerRestricted Stock Units · Derivative | 54,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000011 · edgar.xml · derivative · entry 2 PEAD PHILIP M · CIK 0001227485 · Director · Former Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,554 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On January 13, 2014, the Reporting Person was granted 54,554 performance-based restricted stock units that vest based on Issuer's total shareholder return over a three-year period, as will be determined at the first meeting of the Issuer's compensation committee following November 30, 2016. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested performance-based restricted stock units were cancelled. F3 · derivative.expiration_date: On January 13, 2014, the Reporting Person was granted 54,554 performance-based restricted stock units that vest based on Issuer's total shareholder return over a three-year period, as will be determined at the first meeting of the Issuer's compensation committee following November 30, 2016. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested performance-based restricted stock units were cancelled. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 21:17 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Disposition to issuerRestricted Stock Units · Derivative | 12,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000011 · edgar.xml · derivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director · Former Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,240 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 13, 2014, the Reporting Person was granted 73,437 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2014, subject to the continued employment of the Reporting Person with Issuer. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested restricted stock units were cancelled. F2 · derivative.expiration_date: On January 13, 2014, the Reporting Person was granted 73,437 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2014, subject to the continued employment of the Reporting Person with Issuer. Reporting Person retired as Chief Executive Officer effective October 14, 2016, and the unvested restricted stock units were cancelled. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Exercise / conversionRestricted Stock Units · Derivative | 3,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · derivative · entry 12 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,658 Underlying: Common Stock · 3,731 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F9 · derivative.exercise_date: On January 19, 2016, the Reporting Person was granted 22,389 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2016, subject to the continued employment of the Reporting Person with Issuer. F9 · derivative.expiration_date: On January 19, 2016, the Reporting Person was granted 22,389 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2016, subject to the continued employment of the Reporting Person with Issuer. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Exercise / conversionRestricted Stock Units · Derivative | 2,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · derivative · entry 11 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,718 Underlying: Common Stock · 2,906 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2015, the Reporting Person was granted 17,436 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2015, subject to the continued employment of the Reporting Person with Issuer. F8 · derivative.expiration_date: On March 2, 2015, the Reporting Person was granted 17,436 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2015, subject to the continued employment of the Reporting Person with Issuer. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Exercise / conversionRestricted Stock Units · Derivative | 3,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · derivative · entry 10 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,077 Underlying: Common Stock · 3,661 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.exercise_date: Represents performance-based restricted stock units acquired by the Reporting Person based on Issuer performance in FY15, vesting in five installments, with one-third vesting on April 1, 2016 and the remaining restricted stocuk units vesting in four equal semi-annual installments beginning, subject to the continued employment of the Reporting Person with Issuer. F7 · derivative.expiration_date: Represents performance-based restricted stock units acquired by the Reporting Person based on Issuer performance in FY15, vesting in five installments, with one-third vesting on April 1, 2016 and the remaining restricted stocuk units vesting in four equal semi-annual installments beginning, subject to the continued employment of the Reporting Person with Issuer. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Exercise / conversionRestricted Stock Units · Derivative | 12,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · derivative · entry 9 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,240 Underlying: Common Stock · 12,240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: On January 13, 2014, the Reporting Person was granted 73,437 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2014, subject to the continued employment of the Reporting Person with Issuer. F6 · derivative.expiration_date: On January 13, 2014, the Reporting Person was granted 73,437 restricted stock units, vesting in six equal semi-annual installments beginning on October 1, 2014, subject to the continued employment of the Reporting Person with Issuer. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Tax withholdingCommon Stock | 1,737 | $27.19 | $47,229.03 |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · nonDerivative · entry 8 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,914 F5 · shares: Represents shares of common stock withheld by Issuer to pay tax withholding obligations of the Reporting Person upon the vesting of restricted stock units granted to the Reporting Person on January 19, 2016. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Exercise / conversionCommon Stock | 3,731 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · nonDerivative · entry 7 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Tax withholdingCommon Stock | 1,353 | $27.19 | $36,788.07 |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · nonDerivative · entry 6 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,920 F4 · shares: Represents shares of common stock withheld by Issuer to pay tax withholding obligations of the Reporting Person upon the vesting of restricted stock units granted to the Reporting Person on March 2, 2015. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Exercise / conversionCommon Stock | 2,906 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · nonDerivative · entry 5 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Tax withholdingCommon Stock | 1,704 | $27.19 | $46,331.76 |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · nonDerivative · entry 4 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,367 F3 · shares: Represents shares of common stock withheld by Issuer to pay tax withholding obligations of the Reporting Person upon the vesting of restricted stock units granted to the Reporting Person on March 2, 2015. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Exercise / conversionCommon Stock | 3,661 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · nonDerivative · entry 3 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Tax withholdingCommon Stock | 5,697 | $27.19 | $154,901.43 |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · nonDerivative · entry 2 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,410 F2 · shares: Represents shares of common stock withheld by Issuer to pay tax withholding obligations of the Reporting Person upon the vesting of restricted stock units granted to the Reporting Person on January 13, 2014. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 21:08 UTC | PROGRESS SOFTWARE CORP /MA PRGS · Entity 4559 | Exercise / conversionCommon Stock | 12,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001227485-16-000010 · edgar.xml · nonDerivative · entry 1 PEAD PHILIP M · CIK 0001227485 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.